Across TCGA pan-cancer cohorts, VN1R10P Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated VN1R10P data layer compared with 8 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher VN1R10P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated VN1R10P expression acts as an unfavorable survival marker.

BLCA and TGCT are the cancer types where VN1R10P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.130	0.720	<.001	48	view →
TGCT	DFS	Median	All	0.081	0.801	.005	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: VN1R10P tumor-vs-normal RNA expression · all VN1R10P data types